Diseases

Lennox-Gastaut syndrome. Treatment and Prognosis

Lennox-Gastaut syndrome is a severe form of epilepsy. Seizures begin in early childhood, usually before the age of 4 years.

Children, adolescents, and adults with Lennox-Gastaut syndrome have multiple types of seizures that vary among individuals. Common seizure types include:

  • tonic seizures (stiffening of the body, upward eye gaze, dilated pupils, and altered breathing patterns)
  • atypical absences (staring spells)
  • atonic seizures (brief loss of muscle tone, which could cause abrupt falls)
  • myoclonic seizures (sudden muscle jerks), and
  • generalized tonic-clonic seizures (muscle stiffness and rhythmic jerking).

There may be periods of frequent seizures mixed with relatively seizure-free periods. Although not always present at the onset of seizures, most people with Lennox-Gastaut syndrome experience some degree of impaired intellectual functioning or information processing, along with developmental delays and behavioral disturbances. A particular patten of brain electric activity can be seen using electroencephalogram (EEG). Lennox-Gastaut syndrome can be caused by a variety of conditions, including brain malformations, tuberous sclerosis, perinatal asphyxia, severe head injury, central nervous system infection, and inherited genetic and inherited degenerative or metabolic conditions. In 30-35 percent of individuals, no cause can be found.

Treatment

Lennox-Gastaut syndrome can be very difficult to treat. A combination of seizure medications and other treatments may be used to improve seizure control and other associated conditions.

The medication valproate is generally considered a first-line therapy for various seizure types. Other anticonvulsant medications may include clobazam, felbamate, lamotrigine, rufinamide, topiramate, and cannabidiol. In June 2018 the U.S. Food and Drug Administration approved cannabidiol (Epidolex, derived from marijuana) for the treatment of seizures associated with Lennox-Gastaut syndrome in individuals ages 2 and older.  The drug contains only small amount of the psychoactive element in marijuana and does not induce euphoria associated with the drug.

Other treatment options include dietary therapy with the ketogenic diet, vagus nerve stimulation, and epilepsy surgery (typically a corpus callostomy, which involves severing the band of nerve fibers that connect the two halves of the brain to prevent seizures from spreading). Medication may be combined with the other treatments to optimize seizure control. Children who improve initially may later show tolerance to a drug or have uncontrollable seizures.

Prognosis

The prognosis for individuals with Lennox-Gastaut syndrome varies. There is no cure for the disorder. Complete recovery, including freedom from seizures and normal development, is very rare.

Refer to the Epilepsy Fact sheet for more information and support groups

Medika Life

Medika Life is a digital Health Publication for both the medical profession and the public. Make informed decisions about your health and stay up to date with the latest developments and technological advances in the fields of medicine.

Recent Posts

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Craig Martin is a strategic chameleon in health innovation. He is equally at home in…

15 hours ago

The Silent Additive: What Singapore Street Food Taught Me About Ultra-Processed America

I Ate More. I Weighed Less. In Malaysia, I ate like a poet unchained. Noodles…

16 hours ago

The Algorithm That Gave Me Pause Tonight and “Hooked” Me

I had never envisioned a computer responding to me and “telling” me that it had…

16 hours ago

Why Israel’s Brilliant Climate Solutions Are Still Invisible

If you work in climate or environmental innovation, you’ve probably felt the shift: it’s getting…

1 week ago

The Surprising Health Benefits of Walking on Uneven Ground — And Why You Should Start Today

Most people walk to relax. I came to Borneo to let the ground fight back.…

1 week ago

Human First: Reclaiming Empathy in Our Love Affair with Health Tech

[Reprinted with permission by By Light-it, in collaboration with Digital Health Insider] We are a…

1 week ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More